C World Wide Group Holding A Intercept Pharmaceuticals, Inc. Transaction History

C World Wide Group Holding A

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$85.79 - $126.46 $124,052 - $182,861	-1,446 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$88.49 - $127.55 $17,874 - $25,765	202 Added 16.24%	1,446 $183,000
Q1 2018 May 03, 2018	SELL	$52.72 - $67.25 $2,108 - $2,690	-40 Reduced 3.12%	1,244 $77,000
Q4 2017 Feb 07, 2018	SELL	$58.2 - $72.76 $7,740 - $9,677	-133 Reduced 9.39%	1,284 $75,000
Q3 2017 Nov 06, 2017	BUY	$57.01 - $118.75 $80,783 - $168,268	1,417	1,417 $82,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.